Literature DB >> 12200632

Neural transformation in a pituitary corticotroph adenoma.

Sergio Vidal1, Eva Horvath, Vivian Bonert, Karnig Shahinian, Kalman Kovacs.   

Abstract

A pituitary mass was removed by the transsphenoidal approach from a 63-year-old man with the clinical history and laboratory findings characteristic of Cushing's disease with partial hypopituitarism. Histological, immunohistochemical, ultrastructural and immunoelectron microscopic investigation demonstrated a periodic acid-Schiff-positive, adrenocorticotropic hormone (ACTH)-immunoreactive, pituitary corticotroph adenoma with the formation of neural tissue resembling neuropil within the tumor. The neural elements showed immunopositivity for neurofilament protein and ACTH, but were immunonegative for other adenohypophysial hormones and for corticotropin-releasing hormone. Although the molecular mechanism accounting for neural transformation in this corticotroph adenoma remained obscure, based on the clinical, histological and morphological findings it appears that formation of neural tissue most likely indicate a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200632     DOI: 10.1007/s00401-002-0561-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  3 in total

1.  An intrasellar mixed gangliocytoma-adenoma including ependymal component, and review of the literature.

Authors:  Ping Xiao; Ling Xue; Jian-Jun Peng; Shi-Ting Feng; Bing Liao; Jian-Ming Wen
Journal:  BMJ Case Rep       Date:  2009-04-07

Review 2.  Infrasellar pituitary gangliocytoma causing Cushing's syndrome.

Authors:  Marie-Eve Domingue; Etienne Marbaix; Jean-Luc Do Rego; Vincent Col; Christian Raftopoulos; Thierry Duprez; Hubert Vaudry; Dominique Maiter
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

3.  Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component.

Authors:  Serdar Balci; Arzu Saglam; Hakan Oruckaptan; Tomris Erbas; Figen Soylemezoglu
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.